Status:
UNKNOWN
COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Health Canada
Roche Pharma AG
Conditions:
Covid19
Asymptomatic Shedding Viral
Eligibility:
All Genders
16-80 years
Phase:
NA
Brief Summary
Point-of-care testing can provide an additional layer of protection to reduce transmission of COVID-19 safely and effectively in the population, and if such tests can be self-administered, barriers to...
Detailed Description
In Canada, the age distribution of COVID-19 has demonstrated that young adults are susceptible to infection. As of mid-December, about 19% of cases have occurred in the 20-29 year age group, and about...
Eligibility Criteria
Inclusion
- Male or female aged 16 years and over
- Living or working at University of British Columbia
- Self identified as asymptomatic for COVID-19
- Participants able to give written informed consent
Exclusion
- Anyone who is self identified as having COVID-19 symptoms
- Those diagnosed with COVID-19 in last 30 days
Key Trial Info
Start Date :
May 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2021
Estimated Enrollment :
569 Patients enrolled
Trial Details
Trial ID
NCT04896710
Start Date
May 26 2021
End Date
August 31 2021
Last Update
June 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orchard Commons
Vancouver, British Columbia, Canada, V6T2B5